Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.39 |
| ▸ | KDM4A | O75164 | 1/20 | 0.39 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.39 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5654022 | 1.00 | PTPN1 (0.45) | PTPN1ALDH1A1MAPTTBXAS1KDM1A | |
| SCHEMBL5654019 | 1.00 | PTPN1 (0.45) | PTPN1ALDH1A1MAPTTBXAS1KDM1A | |
| SCHEMBL9751222 | 1.00 | PTPN1 (0.45) | PTPN1ALDH1A1MAPTTBXAS1KDM1A | |
| SCHEMBL1740084 | 1.00 | PTPN1 (0.45) | PTPN1ALDH1A1MAPTTBXAS1KDM1A | |
| SCHEMBL23924669 | 1.00 | PTPN1 (0.45) | PTPN1ALDH1A1MAPTTBXAS1KDM1A | |
| SCHEMBL22555602 | 1.00 | PTPN1 (0.45) | PTPN1ALDH1A1MAPTTBXAS1KDM1A | |
| SCHEMBL23924379 | 1.00 | PTPN1 (0.45) | PTPN1ALDH1A1MAPTTBXAS1KDM1A | |
| SCHEMBL5654028 | 1.00 | PTPN1 (0.45) | PTPN1ALDH1A1MAPTTBXAS1KDM1A | |
| SCHEMBL9751266 | 1.00 | PTPN1 (0.45) | PTPN1ALDH1A1MAPTTBXAS1KDM1A | |
| SCHEMBL1470934 | 1.00 | PTPN1 (0.45) | PTPN1ALDH1A1MAPTTBXAS1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702981-A1 | TARGETED ANTIBACTERIAL TREATMENT | Københavns Universitet (DK) | 2026-03-04 | — | — | EP | claimed |
| CN-118976017-A | Application of medium-carbon-chain olefine acid and derivative thereof in preparation of drugs for promoting angiogenesis and restoring nerve function | 南京邮电大学 | 2024-11-19 | — | — | CN | claimed |
| US-11826333-B2 | Bactericidal debridement compositions for surgical site infections and chronic wound healing | DePuy Synthes Products, Inc. (US) | 2023-11-28 | — | — | US | claimed |
| CN-116725996-A | Application of cis-11-methyl-2-dodecenoic acid in regulating intestinal flora imbalance | 中鑫群感(上海)生物科技有限公司 | 2023-09-12 | — | — | CN | claimed |
| EP-4117651-A1 | BACTERICIDAL DEBRIDEMENT COMPOSITIONS FOR SURGICAL SITE INFECTIONS AND CHRONIC WOUND HEALING | DePuy Synthes Products, Inc. (US) | 2023-01-18 | — | — | EP | claimed |
| CN-115279362-A | Bactericidal debridement composition for surgical site infection and chronic wound healing | 德普伊新特斯产品公司 | 2022-11-01 | — | — | CN | claimed |
| CN-114569477-A | Non-therapeutic use of DSF as cosmetic additive or cosmetic and cosmetic | 苏州药诺泰克新药研发有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114306307-A | Application of DSF in preparing anti-inflammatory drugs or anti-oxidation drugs and drugs | 西安英创生物技术有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-111004737-B | Microbial flora induction signal quenching and sterilization and application thereof in disease prevention and control | 华南农业大学 | 2021-12-24 | — | — | CN | claimed |
| WO-2021181234-A1 | BACTERICIDAL DEBRIDEMENT COMPOSITIONS FOR SURGICAL SITE INFECTIONS AND CHRONIC WOUND HEALING | DePuy Synthes Products, Inc. (US) | 2021-09-16 | — | — | WO | claimed |
| CN-111004737-A | Microbial flora induction signal quenching and sterilization and application thereof in disease prevention and control | 华南农业大学 | 2020-04-14 | — | — | CN | claimed |
| CN-110669687-A | Application of bacillus proteolicus in preventing and treating pathogenic bacteria and diseases depending on quorum sensing signal molecules | 华南农业大学 | 2020-01-10 | — | — | CN | claimed |
| US-20190270909-A1 | CONTROLLED RELEASE OF WATER-SOLUBLE AGENTS | THE SECANT GROUP, LLC | 2019-09-05 | — | — | US | claimed |
| US-10329448-B2 | Method of making coated articles | THE SECANT GROUP, LLC (US) | 2019-06-25 | — | — | US | claimed |
| US-20160251540-A1 | METHOD OF MAKING COATED ARTICLES | THE SECANT GROUP, LLC | 2016-09-01 | — | — | US | claimed |
| US-8748486-B2 | Inhibitors of yeast filamentous growth and method of their manufacture | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2014-06-10 | — | — | US | claimed |
| EP-1684738-B1 | INHIBITORS OF YEAST FILAMENTOUS GROWTH AND METHOD OF THEIR MANUFACTURE | AGENCY SCIENCE TECH & RES (SG) | 2013-07-24 | — | — | EP | claimed |
| EP-1919982-B1 | RADIATION CURABLE CLEARCOAT REPAIR SYSTEM AND METHOD FOR OBTAINING FILM BUILD IN THIN FILM AREAS USING THE SYSTEM | BASF CORP (US) | 2012-03-14 | — | — | EP | claimed |
| US-7915313-B2 | Inhibitors of yeast filamentous growth and method of their manufacture | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-03-29 | — | — | US | claimed |
| US-20060260007-A1 | Inhibitors of yeast filamentous growth and method of their manufacture | AGENCY FOR SCIENCE, TECHNOLOGY AND RESERACH (SG) | 2006-11-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10329448-B2 | Method of making coated articles | SGMS2, SGMS1, RHOA | PTPN1 1239/4885ALDH1A1 3580/4885MAPT 1179/4885 |
| US-20160251540-A1 | METHOD OF MAKING COATED ARTICLES | SGMS2, SGMS1, RHOA | PTPN1 1239/4885ALDH1A1 3580/4885MAPT 1179/4885 |
| US-20190270909-A1 | CONTROLLED RELEASE OF WATER-SOLUBLE AGENTS | ADH1A, ADH1C, MLEC | PTPN1 3863/4885ALDH1A1 1949/4885MAPT 1037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.